Lars Påhlman

33.6k citations

283 papers · 22.8k indexed · 8 hit papers · h-index 67

Impact in

Oncology top 0.02%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
Surgery top 0.02%
- Colorectal and Anal Carcinomas
- Anorectal Disease Treatments and Outcomes
- Diverticular Disease and Complications

Papers in

Oncology 212
- Colorectal Cancer Surgical Treatments 159
- Colorectal Cancer Screening and Detection 74
- Colorectal Cancer Treatments and Studies 47
Surgery 174
- Colorectal and Anal Carcinomas 99
- Anorectal Disease Treatments and Outcomes 38
- Diverticular Disease and Complications 28

Co-authors: Bengt Glimelius Irıs D. Nagtegaal Corrie A.M. Marijnen Theo Wiggers Hein Putter H.J.T. Rutten Cornelis J.�H. van de Velde J.W.H. Leer
Journals: British journal of surgery (22 papers)Diseases of the Colon & Rectum (20 papers)European Journal of Cancer (12 papers)European Journal of Surgical Oncology (12 papers)Colorectal Disease (11 papers)
Partner nations: Sweden Netherlands United Kingdom

In The Last Decade

Lars Påhlman

277 papers receiving 22.1k citations

Hit Papers

8 papers align trajectories log scale

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus 2015 · 376 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Cancer Treatment Reviews
2012 British journal of surgery
2011 The Lancet Oncology
2008 The Lancet Oncology
2007 Annals of Surgery
2005 Journal of Clinical Oncology
2005 The Lancet Oncology
2001 New England Journal of Medicine

Peers

Countries citing papers authored by Lars Påhlman

Since Specialization

Citations

This map shows the geographic impact of Lars Påhlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Påhlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Påhlman more than expected).

Fields of papers citing papers by Lars Påhlman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Påhlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Påhlman. The network helps show where Lars Påhlman may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Påhlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Påhlman Line = papers co-authored together Lars Påhlman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Is England closing the international gap in cancer survival? British Journal of Cancer ·Sarah Walters, Sara Benítez Majano, Patrick Muller, Michel P. Coleman, Claudia Allemani, John Butler, M. Peake, Marianne G. Guren, Bengt Glimelius, Stefan Bergström, Lars Påhlman, Bernard Rachet	2015	74
2	The EURECCA project: Data items scored by European colorectal cancer audit registries European Journal of Surgical Oncology ·W. van Gijn, C.B.M. van den Broek, Paweł Mroczkowski, Adam Dziki, G. Romano, Dainius Pavalkis, Michel W.J.M. Wouters, Bjørn Møller, Arne Wibe, Lars Påhlman, Henrik Harling, Jason Smith, Freddy Penninckx, Héctor Ortiz, Vincenzo Valentini, Cornelis J.�H. van de Velde	2012	24
3	Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa BMC Cancer ·Stefan Enroth, Álvaro Rada-Iglesias, Robin Andersson, Ola Wallerman, Alkwin Wanders, Lars Påhlman, Jan Komorowski, Claes Wadelius	2011	33
4	Mechanical bowel preparation does not affect the intramucosal bacterial colony count International Journal of Colorectal Disease ·Hannelore Brill, Peter Matthiessen, Kenneth Smedh, Erik Nilsson, Ulrika Ransjö, Lars Påhlman	2009	21
5	Laparoscopically Assisted vs Open Colectomy for Colon Cancer Archives of Surgery ·H. J. Bonjer, Wim C.J. Hop, Heidi Nelson, Daniel J. Sargent, Antonio M. Lacy, Antoni Castells, P J Guillou, H. Thorpe, Julia Brown, Salvadora Delgado, Pablo Rivero, Eva Haglind, Lars Påhlman, (unknown)	2007	400
6	Transanal endoscopic microsurgery: clinical and functional results Colorectal Disease ·G. Dafnis, Lars Påhlman, Yngve Raab, Basavaraju Thejur Jayadeva, W. Graf	2004	49
7	Proctocolectomy and pelvic pouch – Is a diverting stoma dangerous for the patient? Colorectal Disease ·Ulf Gunnarsson, Urban Karlbom, M. F. Docker, Yngve Raab, Lars Påhlman	2003	36
8	Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Commentary The Lancet ·Lars Påhlman	2001	434
9	Preoperative irradiation for rectal cancer Lars Påhlman	1998	16
10	Kombinerad strålning och kirurgi bäst mot rectalcancer Läkartidningen ·Lars Påhlman, Ingrid Glimelius	1998	0
11	Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial European Journal of Cancer ·Bengt Glimelius, Anders Jakobsen, W. Graf, Åke Berglund, C. Gadeberg, Per Krogh Hansen, Michael Kjær, PRIYA JAIKUMAR, E. Sandberg, 方子, К Б Гусейнов, Kanagasabapathy Gokulakrishnan, Lars Påhlman, Bengt Gustavsson	1998	41
12	Randomized trial of a biofragmentable bowel anastomosis ring in high-risk colonic resection British journal of surgery ·Lars Påhlman, S Ejerblad, W. Graf, Kaixin Wu, Ulf Kressner, G Lindmark, Yngve Raab	1997	21
13	Functional results after abdominal suture rectopexy for rectal prolapse or intussusception. PubMed ·Wilhelm Graf, Urban Karlbom, Lars Påhlman, S. Nilsson, S Ejerblad	1996	62
14	Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared to surgery alone in resectable rectal carcinoma. The European Journal of Surgery ·Lars Påhlman, Bengt Glimelius	1996	77
15	Prognostic significance of the microvascular count in colorectal cancer. Journal of Clinical Oncology ·G Lindmark, Bengt Gerdin, Christian Sundberg, Lars Påhlman, R Bergström, Bengt Glimelius	1996	88
16	Randomized Comparison of Straight and Colonic J Pouch Anastomosis After Low Anterior Resection Annals of Surgery ·Olof Hallböök, Lars Påhlman, M Krog, Steven D. Wexner, Rune Sjödahl	1996	337
17	Relationships between defecographic findings, rectal emptying, and colonic transit time in constipated patients. Gut ·Urban Karlbom, Lars Påhlman, S. Nilsson, W. Graf	1995	70
18	Increased risk of left sided colon cancer in patients with diverticular disease. Gut ·Tryggvi Stefánsson, Anders Ekbom, Pär Sparén, Lars Påhlman	1993	68
19	The Value of Adjuvant Therapy after Radical Surgery for Colorectal Cancer Annals of Medicine ·Bengt Glimelius, Lars Påhlman	1992	5
20	The risk of subsequent primary malignant diseases after cancers of the colon and rectum a nationwide cohort study Cancer ·Per Enblad, Hans‐Olov Adami, Bengt Glimelius, Krzysztof Chwesiuk, Lars Påhlman	1990	73

About Lars Påhlman

Lars Påhlman is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Gastroenterology and Rheumatology, having authored 283 papers that have together received 22.8k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (159 papers), Colorectal and Anal Carcinomas (99 papers), Colorectal Cancer Screening and Detection (74 papers), Colorectal Cancer Treatments and Studies (47 papers), Anorectal Disease Treatments and Outcomes (38 papers), Genetic factors in colorectal cancer (35 papers), Gastric Cancer Management and Outcomes (30 papers) and Diverticular Disease and Complications (28 papers). The work is most often cited by research in Oncology (18.8k citations), Surgery (15.3k citations), Pulmonary and Respiratory Medicine (4.8k citations), Gastroenterology (558 citations) and Pathology and Forensic Medicine (1.7k citations). Lars Påhlman has collaborated with scholars based in Sweden, Netherlands and United Kingdom. Frequent co-authors include Bengt Glimelius, Irıs D. Nagtegaal, Corrie A.M. Marijnen, Theo Wiggers, Hein Putter, H.J.T. Rutten, Cornelis J.�H. van de Velde, J.W.H. Leer, Ulf Gunnarsson and Ellen Kapiteijn. Their work appears in journals such as British journal of surgery, Diseases of the Colon & Rectum, European Journal of Cancer, European Journal of Surgical Oncology and Colorectal Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact